Gryl, for the Benefit of Shire Pharmaceuticals Group Plc v. Shire Pharmaceuticals Group Plc
537 U.S. 1191
This text of 537 U.S. 1191 (Gryl, for the Benefit of Shire Pharmaceuticals Group Plc v. Shire Pharmaceuticals Group Plc) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Gryl, for the Benefit of Shire Pharmaceuticals Group Plc v. Shire Pharmaceuticals Group Plc, 537 U.S. 1191 (2003).
Opinion
537 U.S. 1191
GRYL ET AL., FOR THE BENEFIT OF SHIRE PHARMACEUTICALS GROUP PLC
v.
SHIRE PHARMACEUTICALS GROUP PLC ET AL.
No. 02-903.
Supreme Court of United States.
February 24, 2003.
CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT.
C. A. 2d Cir. Certiorari denied. Reported below: 298 F. 3d 136.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
537 U.S. 1191, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gryl-for-the-benefit-of-shire-pharmaceuticals-group-plc-v-shire-scotus-2003.